Avatrombopag

Definition: Avatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure. It was approved for medical use in the United States in May 2018, the European Union in June 2019, and Australia in January 2023. source: Wikipedia

ID
770717002
ID date
6 Sep 2021
Previous ID
38728011000001104
Name
Avatrombopag